Therapy for visceral leishmaniasis in HIV-coinfected patients in the Mediterranean area.

Evidence-based recommendation. Strength of recommendation:A = Good evidence to support a recommendation for use; B = Moderate evidence to support a recommendation for use; C = Poor evidence to support a recommendation; D = Moderate evidence to support a recommendation against use; E = Good evidence to support a recommendation against use.
Quality of evidence: I = Evidence from one or more randomized clinical trials; II = Evidence from one or more well-designed clinical trials, without randomization; from cohort or case-controlled analytic studies (preferably from >1 center); from multiple time series; or from dramatic results from uncontrolled experiments; III = Evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees [77], [78]. Abbreviations: IM, intramuscular; IV, intravenous; po, per os.